Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Leap Therapeutics Inc. (LPTX)

3.395   0.145 (4.46%) 09-23 13:21
Open: 3.2 Pre. Close: 3.25
High: 3.47 Low: 3.15
Volume: 5,231,181 Market Cap: 203M
Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company is headquartered in Cambridge, Massachusetts and currently employs 23 full-time employees. The Company’s programs are monoclonal antibodies that target key cellular pathways that enable cancer to grow and spread and specific mechanisms that activate the body’s immune system to identify and attack cancer. DKN-01 and TRX518 are its clinical stage programs. DKN-01 is a monoclonal antibody that inhibits Dickkopf-related protein 1 (DKK1). DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. TRX518 is a monoclonal antibody targeting the glucocorticoid-induced tumor necrosis factor-related receptor (GITR). GITR is a receptor found on the surface of a wide range of immune cells.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.452 - 3.462 3.462 - 3.474
Low: 2.665 - 2.675 2.675 - 2.686
Close: 3.388 - 3.407 3.407 - 3.428

Technical analysis

as of: 2021-09-23 12:43:03 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.39     One year: 5.13
Support: Support1: 2.30    Support2: 1.39
Resistance: Resistance1: 3.76    Resistance2: 4.39
Pivot: 2.09
Moving Average: MA(5): 2.92     MA(20): 2.01
MA(100): 1.69     MA(250): 1.92
MACD: MACD(12,26): 0.35     Signal(9): 0.17
Stochastic oscillator: %K(14,3): 87.96     %D(3): 89.53
RSI: RSI(14): 81.71
52-week: High: 3.76  Low: 1.33  Change(%): 77.6
Average Vol(K): 3-Month: 3181465  10-Days: 2555084

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
LPTX has closed below upper band by 4.0%. Bollinger Bands are 629.6% wider than normal. The large width of the bands suggest high volatility as compared to LPTX's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue.

Headline News

Wed, 22 Sep 2021
Leap (LPTX) falls 4.69% to Close at $3.25 on September 22 - Equities.com

Wed, 22 Sep 2021
Leap Therapeutics Announces Pricing of $90 million of Common Stock and Pre-Funded Warrants - PRNewswire

Tue, 21 Sep 2021
Leap Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GuruFocus.com

Tue, 21 Sep 2021
Is Leap Therapeutics Inc (LPTX) Stock Worth a Buy Tuesday? - InvestorsObserver

Thu, 16 Sep 2021
“The Buzz” Show: Leap Therapeutics, Inc. (NASDAQ: LPTX) Positive Data from Study of Tislelizumab - Financialbuzz.com

Thu, 16 Sep 2021
Leap Therapeutics Presents Updated Positive Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO Congress - PRNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 60
Shares Float (M) 32
% Held by Insiders 12.61
% Held by Institutions 50.48
Shares Short (K) 1,130
Shares Short P. Month (K) 1,510

Stock Financials

EPS -0.417
EPS Est This Year -3.160
EPS Est Next Year -3.090
Book Value (p.s.) 0.640
Profit Margin
Operating Margin -2074.20
Return on Assets (ttm) -52.2
Return on Equity (ttm) -104.4
Qtrly Rev. Growth
Gross Profit (p.s.) 0.025
Sales Per Share 0.025
EBITDA (p.s.) -0.521
Qtrly Earnings Growth
Operating Cash Flow (M) -31
Levered Free Cash Flow (M) -18

Stock Valuations

PE Ratio -7.79
PEG Ratio
Price to Book value 5.08
Price to Sales 129.29
Price to Cash Flow -6.33

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.